{"transactions":[{"id":4631666,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14499,"kind":"person","name":"Stratton John G","position":1,"cik":"0001385262","reported_name":"Stratton John G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2026-10-03T00:11:19.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":397,"price":98.83,"value":39235.51,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":14499,"derivative":{"underlying":"Common Shares","underlying_shares":397},"source":{"system":"sec-edgar","filing":"0001104659-26-113291","document":"tm2626917-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465926113291/tm2626917-5_4seq1.xml","form_type":"4"}},{"id":4631665,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14497,"kind":"person","name":"Gonzalez Patricia Paola","position":1,"cik":"0001879701","reported_name":"Gonzalez Patricia Paola","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2026-10-03T00:11:02.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":333,"price":98.83,"value":32910.39,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":6331,"derivative":{"underlying":"Common Shares","underlying_shares":333},"source":{"system":"sec-edgar","filing":"0001104659-26-113287","document":"tm2626917-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465926113287/tm2626917-4_4seq1.xml","form_type":"4"}},{"id":4631664,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14500,"kind":"person","name":"Conroy Kevin T","position":1,"cik":"0001306119","reported_name":"Conroy Kevin T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2026-10-03T00:10:45.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":318,"price":98.83,"value":31427.94,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":551,"derivative":{"underlying":"Common Shares","underlying_shares":318},"source":{"system":"sec-edgar","filing":"0001104659-26-113286","document":"tm2626917-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465926113286/tm2626917-3_4seq1.xml","form_type":"4"}},{"id":4631661,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14496,"kind":"person","name":"Ahuja Nita","position":1,"cik":"0002102715","reported_name":"Ahuja Nita","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2026-10-03T00:10:33.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":318,"price":98.83,"value":31427.94,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":771,"derivative":{"underlying":"Common Shares","underlying_shares":318},"source":{"system":"sec-edgar","filing":"0001104659-26-113285","document":"tm2626917-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465926113285/tm2626917-2_4seq1.xml","form_type":"4"}},{"id":4631662,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14498,"kind":"person","name":"Roman Michael F","position":1,"cik":"0001577544","reported_name":"Roman Michael F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2026-10-03T00:10:08.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":381,"price":98.83,"value":37654.23,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":7166,"derivative":{"underlying":"Common Shares","underlying_shares":381},"source":{"system":"sec-edgar","filing":"0001104659-26-113280","document":"tm2626917-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000110465926113280/tm2626917-1_4seq1.xml","form_type":"4"}},{"id":4627120,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14500,"kind":"person","name":"Conroy Kevin T","position":1,"cik":"0001306119","reported_name":"Conroy Kevin T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2026-09-25T21:21:14.000Z","date":"2026-09-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":52507,"price":103.99,"value":5460202.93,"ownership":{"direct":true},"balance_after":81230,"source":{"system":"sec-edgar","filing":"0001306119-26-000009","document":"form4-09252026_090910.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1306119/000130611926000009/form4-09252026_090910.xml","form_type":"4"}},{"id":3380,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2347,"kind":"person","name":"MCCOY JOHN A. JR.","position":1,"cik":"0001644207","reported_name":"MCCOY JOHN A. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VICE PRESIDENT AND CONTROLLER"}}],"security":"Common shares without par value","published_at":"2026-09-03T22:11:24.000Z","date":"2026-09-02","kind":"sale","planned":false,"acquired":false,"shares":27,"price":109.54,"value":2957.58,"ownership":{"direct":true},"balance_after":24549,"source":{"system":"sec-edgar","filing":"0001644207-26-000012","document":"form4-09032026_100920.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1644207/000164420726000012/form4-09032026_100920.xml","form_type":"4"}},{"id":3379,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2347,"kind":"person","name":"MCCOY JOHN A. JR.","position":1,"cik":"0001644207","reported_name":"MCCOY JOHN A. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VICE PRESIDENT AND CONTROLLER"}}],"security":"Common shares without par value","published_at":"2026-09-03T22:11:24.000Z","date":"2026-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":52,"price":110.36,"value":5738.72,"ownership":{"direct":true},"balance_after":24576,"source":{"system":"sec-edgar","filing":"0001644207-26-000012","document":"form4-09032026_100920.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1644207/000164420726000012/form4-09032026_100920.xml","form_type":"4"}},{"id":3327,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2315,"kind":"person","name":"Boudreau Philip P","position":1,"cik":"0001805099","reported_name":"Boudreau Philip P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND CFO"}}],"security":"Common shares without par value","published_at":"2026-09-03T22:02:03.000Z","date":"2026-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":388,"price":110.36,"value":42819.68,"ownership":{"direct":true},"balance_after":70784,"source":{"system":"sec-edgar","filing":"0001805099-26-000008","document":"form4-09032026_100959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805099/000180509926000008/form4-09032026_100959.xml","form_type":"4"}},{"id":305638,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14218,"kind":"person","name":"Ford Robert B","position":1,"cik":"0001612571","reported_name":"Ford Robert B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN AND CEO"}}],"security":"Option (right to buy)","published_at":"2026-08-27T21:09:42.000Z","date":"2026-08-25","kind":"exercise","planned":false,"acquired":false,"shares":246963,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":59.94,"exercise_date":"2021-02-16","expiration_date":"2028-02-15","underlying":"Common Shares","underlying_shares":246963},"source":{"system":"sec-edgar","filing":"0001612571-26-000011","document":"form4-08272026_090838.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1800/000161257126000011/form4-08272026_090838.xml","form_type":"4"}},{"id":305637,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14218,"kind":"person","name":"Ford Robert B","position":1,"cik":"0001612571","reported_name":"Ford Robert B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN AND CEO"}}],"security":"Option (right to buy)","published_at":"2026-08-27T21:09:42.000Z","date":"2026-08-25","kind":"exercise","planned":false,"acquired":false,"shares":151869,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":44.4,"exercise_date":"2020-02-17","expiration_date":"2027-02-16","underlying":"Common Shares","underlying_shares":151869},"source":{"system":"sec-edgar","filing":"0001612571-26-000011","document":"form4-08272026_090838.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1800/000161257126000011/form4-08272026_090838.xml","form_type":"4"}},{"id":305636,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14218,"kind":"person","name":"Ford Robert B","position":1,"cik":"0001612571","reported_name":"Ford Robert B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN AND CEO"}}],"security":"Common shares without par value","published_at":"2026-08-27T21:09:42.000Z","date":"2026-08-25","kind":"sale","planned":false,"acquired":false,"shares":180297,"price":116.19,"value":20948708.43,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.09 to $116.36, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":306461,"source":{"system":"sec-edgar","filing":"0001612571-26-000011","document":"form4-08272026_090838.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1800/000161257126000011/form4-08272026_090838.xml","form_type":"4"}},{"id":305635,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14218,"kind":"person","name":"Ford Robert B","position":1,"cik":"0001612571","reported_name":"Ford Robert B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN AND CEO"}}],"security":"Common shares without par value","published_at":"2026-08-27T21:09:42.000Z","date":"2026-08-25","kind":"sale","planned":false,"acquired":false,"shares":218535,"price":115.57,"value":25256089.95,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.09 to $116.08, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":486758,"source":{"system":"sec-edgar","filing":"0001612571-26-000011","document":"form4-08272026_090838.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000161257126000011/form4-08272026_090838.xml","form_type":"4"}},{"id":305634,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14218,"kind":"person","name":"Ford Robert B","position":1,"cik":"0001612571","reported_name":"Ford Robert B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN AND CEO"}}],"security":"Common shares without par value","published_at":"2026-08-27T21:09:42.000Z","date":"2026-08-25","kind":"exercise","planned":false,"acquired":true,"shares":246963,"price":59.94,"value":14802962.22,"ownership":{"direct":true},"balance_after":705293,"source":{"system":"sec-edgar","filing":"0001612571-26-000011","document":"form4-08272026_090838.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000161257126000011/form4-08272026_090838.xml","form_type":"4"}},{"id":305633,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14218,"kind":"person","name":"Ford Robert B","position":1,"cik":"0001612571","reported_name":"Ford Robert B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN AND CEO"}}],"security":"Common shares without par value","published_at":"2026-08-27T21:09:42.000Z","date":"2026-08-25","kind":"exercise","planned":false,"acquired":true,"shares":151869,"price":44.4,"value":6742983.6,"ownership":{"direct":true},"balance_after":458330,"source":{"system":"sec-edgar","filing":"0001612571-26-000011","document":"form4-08272026_090838.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000161257126000011/form4-08272026_090838.xml","form_type":"4"}},{"id":306301,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14307,"kind":"person","name":"Morrone Louis H.","position":1,"cik":"0001867666","reported_name":"Morrone Louis H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2026-08-13T21:14:48.000Z","date":"2026-08-12","kind":"other","planned":false,"acquired":false,"shares":12,"price":107.99,"value":1295.88,"ownership":{"direct":false,"nature":"Profit Sharing Trust"},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001867666-26-000013","document":"form4-08132026_090844.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000186766626000013/form4-08132026_090844.xml","form_type":"4"}},{"id":306300,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14307,"kind":"person","name":"Morrone Louis H.","position":1,"cik":"0001867666","reported_name":"Morrone Louis H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2026-08-13T21:14:48.000Z","date":"2026-08-11","kind":"sale","planned":false,"acquired":false,"shares":5850,"price":109.83,"value":642505.5,"ownership":{"direct":true},"balance_after":70724,"source":{"system":"sec-edgar","filing":"0001867666-26-000013","document":"form4-08132026_090844.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000186766626000013/form4-08132026_090844.xml","form_type":"4"}},{"id":307687,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14499,"kind":"person","name":"Stratton John G","position":1,"cik":"0001385262","reported_name":"Stratton John G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2026-07-01T22:00:07.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":432,"price":90.74,"value":39199.68,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":14022,"derivative":{"underlying":"Common Shares","underlying_shares":432},"source":{"system":"sec-edgar","filing":"0001385262-26-000019","document":"form4-07012026_100703.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000138526226000019/form4-07012026_100703.xml","form_type":"4"}},{"id":307683,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14498,"kind":"person","name":"Roman Michael F","position":1,"cik":"0001577544","reported_name":"Roman Michael F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2026-07-01T21:53:48.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":416,"price":90.74,"value":37747.84,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":6746,"derivative":{"underlying":"Common Shares","underlying_shares":416},"source":{"system":"sec-edgar","filing":"0001577544-26-000010","document":"form4-07012026_090744.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000157754426000010/form4-07012026_090744.xml","form_type":"4"}},{"id":307631,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14497,"kind":"person","name":"Gonzalez Patricia Paola","position":1,"cik":"0001879701","reported_name":"Gonzalez Patricia Paola","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2026-07-01T21:40:49.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":363,"price":90.74,"value":32938.62,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":5963,"derivative":{"underlying":"Common Shares","underlying_shares":363},"source":{"system":"sec-edgar","filing":"0001879701-26-000008","document":"form4-07012026_090745.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000187970126000008/form4-07012026_090745.xml","form_type":"4"}},{"id":307696,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14500,"kind":"person","name":"Conroy Kevin T","position":1,"cik":"0001306119","reported_name":"Conroy Kevin T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2026-07-01T21:28:11.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":231,"price":90.74,"value":20960.94,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott stock."}],"balance_after":231,"derivative":{"underlying":"Common Shares","underlying_shares":231},"source":{"system":"sec-edgar","filing":"0001306119-26-000006","document":"form4-07012026_090707.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000130611926000006/form4-07012026_090707.xml","form_type":"4"}},{"id":307630,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14496,"kind":"person","name":"Ahuja Nita","position":1,"cik":"0002102715","reported_name":"Ahuja Nita","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2026-07-01T21:15:42.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":347,"price":90.74,"value":31486.78,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":450,"derivative":{"underlying":"Common Shares","underlying_shares":347},"source":{"system":"sec-edgar","filing":"0002102715-26-000006","document":"form4-07012026_090738.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000210271526000006/form4-07012026_090738.xml","form_type":"4"}},{"id":307650,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14307,"kind":"person","name":"Morrone Louis H.","position":1,"cik":"0001867666","reported_name":"Morrone Louis H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2026-07-01T21:04:30.000Z","date":"2026-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":269,"price":92.71,"value":24938.99,"ownership":{"direct":true},"balance_after":76574,"source":{"system":"sec-edgar","filing":"0001867666-26-000009","document":"form4-07012026_090726.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000186766626000009/form4-07012026_090726.xml","form_type":"4"}},{"id":307717,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14512,"kind":"person","name":"Cushman Elizabeth C.","position":1,"cik":"0002075371","reported_name":"Cushman Elizabeth C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common shares without par value","published_at":"2026-06-29T21:34:25.000Z","date":"2026-06-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":560,"price":94.12,"value":52707.2,"ownership":{"direct":true},"balance_after":38013,"source":{"system":"sec-edgar","filing":"0002075371-26-000009","document":"form4-06292026_090621.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000207537126000009/form4-06292026_090621.xml","form_type":"4"}},{"id":308126,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14499,"kind":"person","name":"Stratton John G","position":1,"cik":"0001385262","reported_name":"Stratton John G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2026-06-18T21:08:30.000Z","date":"2026-05-07","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":86.82,"value":173640.0,"ownership":{"direct":true},"balance_after":23319,"source":{"system":"sec-edgar","filing":"0001385262-26-000017","document":"form4-06182026_090625.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000138526226000017/form4-06182026_090625.xml","form_type":"4"}},{"id":310267,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2026-04-29T21:09:00.000Z","date":"2026-04-28","kind":"other","planned":false,"acquired":true,"shares":5314,"price":94.41,"value":501694.74,"ownership":{"direct":false,"nature":"Profit Sharing Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Balance in the Abbott Laboratories Stock Retirement Trust as of April 28, 2026."}],"balance_after":17159,"source":{"system":"sec-edgar","filing":"0001783147-26-000009","document":"form4-04292026_090456.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000178314726000009/form4-04292026_090456.xml","form_type":"4"}},{"id":310315,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14500,"kind":"person","name":"Conroy Kevin T","position":1,"cik":"0001306119","reported_name":"Conroy Kevin T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2026-04-29T00:07:28.000Z","date":"2026-04-24","kind":"grant","planned":false,"acquired":true,"shares":2286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award granted under the Abbott Laboratories 2026 Incentive Stock Program (the \"Program\"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined by the Program)."}],"balance_after":133737,"source":{"system":"sec-edgar","filing":"0001306119-26-000004","document":"form4-04292026_120423.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000130611926000004/form4-04292026_120423.xml","form_type":"4"}},{"id":310314,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14499,"kind":"person","name":"Stratton John G","position":1,"cik":"0001385262","reported_name":"Stratton John G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2026-04-28T23:45:16.000Z","date":"2026-04-24","kind":"grant","planned":false,"acquired":true,"shares":2286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award granted under the Abbott Laboratories 2026 Incentive Stock Program (the \"Program\"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":21319,"source":{"system":"sec-edgar","filing":"0001385262-26-000012","document":"form4-04282026_110409.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000138526226000012/form4-04282026_110409.xml","form_type":"4"}},{"id":310320,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2026-04-28T23:37:56.000Z","date":"2026-04-24","kind":"grant","planned":false,"acquired":true,"shares":7105,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Stock option granted under the Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":7105,"derivative":{"exercise_price":91.86,"exercise_date":"2026-04-24","expiration_date":"2036-04-23","underlying":"Common Shares","underlying_shares":7105},"source":{"system":"sec-edgar","filing":"0000902132-26-000005","document":"form4-04282026_110450.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1800/000090213226000005/form4-04282026_110450.xml","form_type":"4"}},{"id":310319,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2026-04-28T23:37:56.000Z","date":"2026-04-27","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":92.6537,"value":926537.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.43 to $93.04, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":6751103,"source":{"system":"sec-edgar","filing":"0000902132-26-000005","document":"form4-04282026_110450.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000090213226000005/form4-04282026_110450.xml","form_type":"4"}},{"id":310318,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2026-04-28T23:37:56.000Z","date":"2026-04-24","kind":"grant","planned":false,"acquired":true,"shares":2286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award granted under the Abbott Laboratories 2026 Incentive Stock Program (the \"Program\"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":6741103,"source":{"system":"sec-edgar","filing":"0000902132-26-000005","document":"form4-04282026_110450.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000090213226000005/form4-04282026_110450.xml","form_type":"4"}},{"id":310310,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14498,"kind":"person","name":"Roman Michael F","position":1,"cik":"0001577544","reported_name":"Roman Michael F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2026-04-28T23:21:14.000Z","date":"2026-04-24","kind":"grant","planned":false,"acquired":true,"shares":2286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award granted under the Abbott Laboratories 2026 Incentive Stock Program (the \"Program\"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":10764,"source":{"system":"sec-edgar","filing":"0001577544-26-000006","document":"form4-04282026_110409.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000157754426000006/form4-04282026_110409.xml","form_type":"4"}},{"id":310313,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14741,"kind":"person","name":"O'Grady Michael","position":1,"cik":"0001527742","reported_name":"O'Grady Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2026-04-28T23:14:10.000Z","date":"2026-04-24","kind":"grant","planned":false,"acquired":true,"shares":5929,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Stock option granted under the Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":5929,"derivative":{"exercise_price":91.86,"exercise_date":"2026-04-24","expiration_date":"2036-04-23","underlying":"Common Shares","underlying_shares":5929},"source":{"system":"sec-edgar","filing":"0001527742-26-000012","document":"form4-04282026_110406.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000152774226000012/form4-04282026_110406.xml","form_type":"4"}},{"id":310312,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14741,"kind":"person","name":"O'Grady Michael","position":1,"cik":"0001527742","reported_name":"O'Grady Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2026-04-28T23:14:10.000Z","date":"2026-04-24","kind":"grant","planned":false,"acquired":true,"shares":2286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award granted under the Abbott Laboratories 2026 Incentive Stock Program (the \"Program\"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":7603,"source":{"system":"sec-edgar","filing":"0001527742-26-000012","document":"form4-04282026_110406.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000152774226000012/form4-04282026_110406.xml","form_type":"4"}},{"id":310317,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14742,"kind":"person","name":"McKinstry Nancy","position":1,"cik":"0001294731","reported_name":"McKinstry Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2026-04-28T23:02:40.000Z","date":"2026-04-24","kind":"grant","planned":false,"acquired":true,"shares":2305,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Stock option granted under the Program, in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":2305,"derivative":{"exercise_price":91.86,"exercise_date":"2026-04-24","expiration_date":"2036-04-23","underlying":"Common Shares","underlying_shares":2305},"source":{"system":"sec-edgar","filing":"0001294731-26-000004","document":"form4-04282026_110436.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000129473126000004/form4-04282026_110436.xml","form_type":"4"}},{"id":310316,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14742,"kind":"person","name":"McKinstry Nancy","position":1,"cik":"0001294731","reported_name":"McKinstry Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2026-04-28T23:02:40.000Z","date":"2026-04-24","kind":"grant","planned":false,"acquired":true,"shares":2286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award granted under the Abbott Laboratories 2026 Incentive Stock Program (the \"Program\"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":41010,"source":{"system":"sec-edgar","filing":"0001294731-26-000004","document":"form4-04282026_110436.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000129473126000004/form4-04282026_110436.xml","form_type":"4"}},{"id":310306,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10853,"kind":"person","name":"McDew Darren W","position":1,"cik":"0001787479","reported_name":"McDew Darren W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2026-04-28T22:54:45.000Z","date":"2026-04-24","kind":"grant","planned":false,"acquired":true,"shares":2286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award granted under the Abbott Laboratories 2026 Incentive Stock Program (the \"Program\"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":12678,"source":{"system":"sec-edgar","filing":"0001787479-26-000003","document":"form4-04282026_100441.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000178747926000003/form4-04282026_100441.xml","form_type":"4"}},{"id":310309,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14739,"kind":"person","name":"Kumbier Michelle","position":1,"cik":"0001640036","reported_name":"Kumbier Michelle","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2026-04-28T22:45:45.000Z","date":"2026-04-24","kind":"grant","planned":false,"acquired":true,"shares":2286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award granted under the Abbott Laboratories 2026 Incentive Stock Program (the \"Program\"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":18000,"source":{"system":"sec-edgar","filing":"0001640036-26-000004","document":"form4-04282026_100440.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000164003626000004/form4-04282026_100440.xml","form_type":"4"}},{"id":310302,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14497,"kind":"person","name":"Gonzalez Patricia Paola","position":1,"cik":"0001879701","reported_name":"Gonzalez Patricia Paola","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2026-04-28T22:27:12.000Z","date":"2026-04-24","kind":"grant","planned":false,"acquired":true,"shares":2286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award granted under the Abbott Laboratories 2026 Incentive Stock Program (the \"Program\"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":9205,"source":{"system":"sec-edgar","filing":"0001879701-26-000006","document":"form4-04282026_100407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000187970126000006/form4-04282026_100407.xml","form_type":"4"}},{"id":310311,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14740,"kind":"person","name":"Blount Sally E.","position":1,"cik":"0001537286","reported_name":"Blount Sally E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2026-04-28T22:17:13.000Z","date":"2026-04-24","kind":"grant","planned":false,"acquired":true,"shares":2286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award granted under the Abbott Laboratories 2017 Incentive Stock Program (the \"Program\"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":36344,"source":{"system":"sec-edgar","filing":"0001537286-26-000002","document":"form4-04282026_100406.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000153728626000002/form4-04282026_100406.xml","form_type":"4"}},{"id":310307,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14738,"kind":"person","name":"Babineaux-Fontenot Claire","position":1,"cik":"0001736637","reported_name":"Babineaux-Fontenot Claire","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2026-04-28T22:09:05.000Z","date":"2026-04-24","kind":"grant","planned":false,"acquired":true,"shares":2286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award granted under the Abbott Laboratories 2026 Incentive Stock Program (the \"Program\"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":7603,"source":{"system":"sec-edgar","filing":"0001736637-26-000002","document":"form4-04282026_100459.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000173663726000002/form4-04282026_100459.xml","form_type":"4"}},{"id":310301,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14496,"kind":"person","name":"Ahuja Nita","position":1,"cik":"0002102715","reported_name":"Ahuja Nita","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2026-04-28T22:01:45.000Z","date":"2026-04-24","kind":"grant","planned":false,"acquired":true,"shares":2286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award granted under the Abbott Laboratories 2026 Incentive Stock Program (the \"Program\"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program)."}],"balance_after":2286,"source":{"system":"sec-edgar","filing":"0002102715-26-000004","document":"form4-04282026_100439.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000210271526000004/form4-04282026_100439.xml","form_type":"4"}},{"id":310336,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2315,"kind":"person","name":"Boudreau Philip P","position":1,"cik":"0001805099","reported_name":"Boudreau Philip P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND CFO"}}],"security":"Common shares without par value","published_at":"2026-04-27T21:34:47.000Z","date":"2026-04-23","kind":"purchase","planned":false,"acquired":true,"shares":2200,"price":91.5,"value":201300.0,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":2200,"source":{"system":"sec-edgar","filing":"0001805099-26-000006","document":"form4-04272026_090443.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000180509926000006/form4-04272026_090443.xml","form_type":"4"}},{"id":310335,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2315,"kind":"person","name":"Boudreau Philip P","position":1,"cik":"0001805099","reported_name":"Boudreau Philip P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND CFO"}}],"security":"Common shares without par value","published_at":"2026-04-27T21:34:47.000Z","date":"2026-04-23","kind":"other","planned":false,"acquired":true,"shares":8909,"price":92.04,"value":819984.36,"ownership":{"direct":false,"nature":"Profit Sharing Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Balance in the Abbott Laboratories Stock Retirement Trust as of April 23, 2026."}],"balance_after":9276,"source":{"system":"sec-edgar","filing":"0001805099-26-000006","document":"form4-04272026_090443.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000180509926000006/form4-04272026_090443.xml","form_type":"4"}},{"id":310948,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14499,"kind":"person","name":"Stratton John G","position":1,"cik":"0001385262","reported_name":"Stratton John G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2026-04-02T21:31:52.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":382,"price":102.67,"value":39219.94,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":13489,"derivative":{"underlying":"Common Shares","underlying_shares":382},"source":{"system":"sec-edgar","filing":"0001385262-26-000010","document":"form4-04022026_090447.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000138526226000010/form4-04022026_090447.xml","form_type":"4"}},{"id":310941,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14498,"kind":"person","name":"Roman Michael F","position":1,"cik":"0001577544","reported_name":"Roman Michael F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2026-04-02T21:24:18.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":367,"price":102.67,"value":37679.89,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":6283,"derivative":{"underlying":"Common Shares","underlying_shares":367},"source":{"system":"sec-edgar","filing":"0001577544-26-000004","document":"form4-04022026_090414.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000157754426000004/form4-04022026_090414.xml","form_type":"4"}},{"id":310913,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14497,"kind":"person","name":"Gonzalez Patricia Paola","position":1,"cik":"0001879701","reported_name":"Gonzalez Patricia Paola","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2026-04-02T21:15:44.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":321,"price":102.67,"value":32957.07,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":5558,"derivative":{"underlying":"Common Shares","underlying_shares":321},"source":{"system":"sec-edgar","filing":"0001879701-26-000004","document":"form4-04022026_090438.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000187970126000004/form4-04022026_090438.xml","form_type":"4"}},{"id":310946,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2026-04-02T21:07:24.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":76,"price":102.67,"value":7802.92,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":10544,"derivative":{"underlying":"Common Shares","underlying_shares":76},"source":{"system":"sec-edgar","filing":"0001448074-26-000008","document":"form4-04022026_090418.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000144807426000008/form4-04022026_090418.xml","form_type":"4"}},{"id":310894,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14496,"kind":"person","name":"Ahuja Nita","position":1,"cik":"0002102715","reported_name":"Ahuja Nita","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2026-04-02T21:00:50.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":102,"price":102.67,"value":10472.34,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."}],"balance_after":102,"derivative":{"underlying":"Common Shares","underlying_shares":102},"source":{"system":"sec-edgar","filing":"0002102715-26-000002","document":"form4-04022026_090445.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000210271526000002/form4-04022026_090445.xml","form_type":"4"}},{"id":311178,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14802,"kind":"person","name":"ORVILLE JACOB A","position":1,"cik":"0001263312","reported_name":"ORVILLE JACOB A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2026-03-25T22:56:57.000Z","date":"2026-03-23","kind":"grant","planned":false,"acquired":true,"shares":13255,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 2-year term, with 1/2 of the award vesting in any one year, beginning on March 23, 2027. The award includes the right to have shares withheld for tax purposes."}],"balance_after":50493,"source":{"system":"sec-edgar","filing":"0001263312-26-000004","document":"form4-03252026_100352.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000126331226000004/form4-03252026_100352.xml","form_type":"4"}},{"id":312131,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14867,"kind":"person","name":"Shroff Eric","position":1,"cik":"0002058129","reported_name":"Shroff Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2026-03-04T01:20:08.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":709,"price":115.58,"value":81946.22,"ownership":{"direct":true},"balance_after":39164,"source":{"system":"sec-edgar","filing":"0002058129-26-000007","document":"form4-03042026_010300.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000205812926000007/form4-03042026_010300.xml","form_type":"4"}},{"id":312130,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14867,"kind":"person","name":"Shroff Eric","position":1,"cik":"0002058129","reported_name":"Shroff Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2026-03-04T01:20:08.000Z","date":"2026-02-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":1384,"price":116.26,"value":160903.84,"ownership":{"direct":true},"balance_after":39873,"source":{"system":"sec-edgar","filing":"0002058129-26-000007","document":"form4-03042026_010300.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000205812926000007/form4-03042026_010300.xml","form_type":"4"}},{"id":312203,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14877,"kind":"person","name":"Scoggins Christopher J","position":1,"cik":"0001772286","reported_name":"Scoggins Christopher J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2026-03-04T01:15:27.000Z","date":"2026-02-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":4997,"price":116.26,"value":580951.22,"ownership":{"direct":true},"balance_after":77126,"source":{"system":"sec-edgar","filing":"0001772286-26-000004","document":"form4-03042026_010323.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000177228626000004/form4-03042026_010323.xml","form_type":"4"}},{"id":312256,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GROUP PRESIDENT"}}],"security":"Common shares without par value","published_at":"2026-03-04T01:10:48.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":885,"price":115.58,"value":102288.3,"ownership":{"direct":true},"balance_after":146377,"source":{"system":"sec-edgar","filing":"0001620564-26-000007","document":"form4-03042026_010342.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000162056426000007/form4-03042026_010342.xml","form_type":"4"}},{"id":312255,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GROUP PRESIDENT"}}],"security":"Common shares without par value","published_at":"2026-03-04T01:10:48.000Z","date":"2026-02-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":6615,"price":116.26,"value":769059.9,"ownership":{"direct":true},"balance_after":147262,"source":{"system":"sec-edgar","filing":"0001620564-26-000007","document":"form4-03042026_010342.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000162056426000007/form4-03042026_010342.xml","form_type":"4"}},{"id":312188,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14307,"kind":"person","name":"Morrone Louis H.","position":1,"cik":"0001867666","reported_name":"Morrone Louis H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2026-03-04T01:06:54.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":1144,"price":115.58,"value":132223.52,"ownership":{"direct":true},"balance_after":76843,"source":{"system":"sec-edgar","filing":"0001867666-26-000007","document":"form4-03042026_010349.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000186766626000007/form4-03042026_010349.xml","form_type":"4"}},{"id":312187,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14307,"kind":"person","name":"Morrone Louis H.","position":1,"cik":"0001867666","reported_name":"Morrone Louis H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2026-03-04T01:06:54.000Z","date":"2026-02-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":4040,"price":116.26,"value":469690.4,"ownership":{"direct":true},"balance_after":77987,"source":{"system":"sec-edgar","filing":"0001867666-26-000007","document":"form4-03042026_010349.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000186766626000007/form4-03042026_010349.xml","form_type":"4"}},{"id":312202,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2026-03-04T01:00:16.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":613,"price":115.58,"value":70850.54,"ownership":{"direct":true},"balance_after":104291,"source":{"system":"sec-edgar","filing":"0001783147-26-000007","document":"form4-03042026_010311.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000178314726000007/form4-03042026_010311.xml","form_type":"4"}},{"id":312201,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2026-03-04T01:00:16.000Z","date":"2026-02-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":4630,"price":116.26,"value":538283.8,"ownership":{"direct":true},"balance_after":104904,"source":{"system":"sec-edgar","filing":"0001783147-26-000007","document":"form4-03042026_010311.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000178314726000007/form4-03042026_010311.xml","form_type":"4"}},{"id":312246,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2347,"kind":"person","name":"MCCOY JOHN A. JR.","position":1,"cik":"0001644207","reported_name":"MCCOY JOHN A. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VICE PRESIDENT AND CONTROLLER"}}],"security":"Common shares without par value","published_at":"2026-03-04T00:55:24.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":585,"price":115.58,"value":67614.3,"ownership":{"direct":true},"balance_after":24628,"source":{"system":"sec-edgar","filing":"0001644207-26-000007","document":"form4-03042026_120315.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000164420726000007/form4-03042026_120315.xml","form_type":"4"}},{"id":312245,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2347,"kind":"person","name":"MCCOY JOHN A. JR.","position":1,"cik":"0001644207","reported_name":"MCCOY JOHN A. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VICE PRESIDENT AND CONTROLLER"}}],"security":"Common shares without par value","published_at":"2026-03-04T00:55:24.000Z","date":"2026-02-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":1142,"price":116.26,"value":132768.92,"ownership":{"direct":true},"balance_after":25213,"source":{"system":"sec-edgar","filing":"0001644207-26-000007","document":"form4-03042026_120315.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000164420726000007/form4-03042026_120315.xml","form_type":"4"}},{"id":312257,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14218,"kind":"person","name":"Ford Robert B","position":1,"cik":"0001612571","reported_name":"Ford Robert B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN AND CEO"}}],"security":"Common shares without par value","published_at":"2026-03-04T00:48:46.000Z","date":"2026-02-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":30308,"price":116.26,"value":3523608.08,"ownership":{"direct":true},"balance_after":306461,"source":{"system":"sec-edgar","filing":"0001612571-26-000006","document":"form4-03042026_120340.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000161257126000006/form4-03042026_120340.xml","form_type":"4"}},{"id":312270,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GROUP PRESIDENT"}}],"security":"Common shares without par value","published_at":"2026-03-04T00:44:17.000Z","date":"2026-02-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":8577,"price":116.26,"value":997162.02,"ownership":{"direct":true},"balance_after":90407,"source":{"system":"sec-edgar","filing":"0001530893-26-000004","document":"form4-03042026_120314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000153089326000004/form4-03042026_120314.xml","form_type":"4"}},{"id":312129,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14512,"kind":"person","name":"Cushman Elizabeth C.","position":1,"cik":"0002075371","reported_name":"Cushman Elizabeth C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common shares without par value","published_at":"2026-03-04T00:39:39.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":263,"price":115.58,"value":30397.54,"ownership":{"direct":true},"balance_after":38573,"source":{"system":"sec-edgar","filing":"0002075371-26-000007","document":"form4-03042026_120334.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000207537126000007/form4-03042026_120334.xml","form_type":"4"}},{"id":312128,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14512,"kind":"person","name":"Cushman Elizabeth C.","position":1,"cik":"0002075371","reported_name":"Cushman Elizabeth C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common shares without par value","published_at":"2026-03-04T00:39:39.000Z","date":"2026-02-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":1421,"price":116.26,"value":165205.46,"ownership":{"direct":true},"balance_after":38836,"source":{"system":"sec-edgar","filing":"0002075371-26-000007","document":"form4-03042026_120334.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000207537126000007/form4-03042026_120334.xml","form_type":"4"}},{"id":312195,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2315,"kind":"person","name":"Boudreau Philip P","position":1,"cik":"0001805099","reported_name":"Boudreau Philip P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND CFO"}}],"security":"Common shares without par value","published_at":"2026-03-04T00:34:03.000Z","date":"2026-02-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":7441,"price":116.26,"value":865090.66,"ownership":{"direct":true},"balance_after":71172,"source":{"system":"sec-edgar","filing":"0001805099-26-000004","document":"form4-03042026_120355.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000180509926000004/form4-03042026_120355.xml","form_type":"4"}},{"id":312665,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14867,"kind":"person","name":"Shroff Eric","position":1,"cik":"0002058129","reported_name":"Shroff Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Option (right to buy)","published_at":"2026-02-27T00:24:53.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":44821,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 14,940 on February 24, 2027, 14,940 on February 24, 2028, and 14,941\non February 24, 2029."}],"balance_after":44821,"derivative":{"exercise_price":114.6,"exercise_date":"2027-02-24","expiration_date":"2036-02-23","underlying":"Common Shares","underlying_shares":44821},"source":{"system":"sec-edgar","filing":"0002058129-26-000002","document":"form4-02272026_120249.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000205812926000002/form4-02272026_120249.xml","form_type":"4"}},{"id":312664,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14867,"kind":"person","name":"Shroff Eric","position":1,"cik":"0002058129","reported_name":"Shroff Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2026-02-27T00:24:53.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":10873,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":41257,"source":{"system":"sec-edgar","filing":"0002058129-26-000002","document":"form4-02272026_120249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000205812926000002/form4-02272026_120249.xml","form_type":"4"}},{"id":312701,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14877,"kind":"person","name":"Scoggins Christopher J","position":1,"cik":"0001772286","reported_name":"Scoggins Christopher J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2026-02-27T00:15:24.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":76273,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 25,424 on February 24, 2027, 25,424 on February 24, 2028, and 25,425\non February 24, 2029."}],"balance_after":76273,"derivative":{"exercise_price":114.6,"exercise_date":"2027-02-24","expiration_date":"2036-02-23","underlying":"Common Shares","underlying_shares":76273},"source":{"system":"sec-edgar","filing":"0001772286-26-000002","document":"form4-02272026_120215.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000177228626000002/form4-02272026_120215.xml","form_type":"4"}},{"id":312700,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14877,"kind":"person","name":"Scoggins Christopher J","position":1,"cik":"0001772286","reported_name":"Scoggins Christopher J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2026-02-27T00:15:24.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":18502,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":82123,"source":{"system":"sec-edgar","filing":"0001772286-26-000002","document":"form4-02272026_120215.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000177228626000002/form4-02272026_120215.xml","form_type":"4"}},{"id":312712,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GROUP PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2026-02-27T00:02:35.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":89226,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 29,742 on February 24, 2027, 29,742 on February 24, 2028, and 29,742\n  on February 24, 2029."}],"balance_after":89226,"derivative":{"exercise_price":114.6,"exercise_date":"2027-02-24","expiration_date":"2036-02-23","underlying":"Common Shares","underlying_shares":89226},"source":{"system":"sec-edgar","filing":"0001620564-26-000002","document":"form4-02272026_120229.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000162056426000002/form4-02272026_120229.xml","form_type":"4"}},{"id":312711,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GROUP PRESIDENT"}}],"security":"Common shares without par value","published_at":"2026-02-27T00:02:35.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":21644,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":153877,"source":{"system":"sec-edgar","filing":"0001620564-26-000002","document":"form4-02272026_120229.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000162056426000002/form4-02272026_120229.xml","form_type":"4"}},{"id":312692,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14307,"kind":"person","name":"Morrone Louis H.","position":1,"cik":"0001867666","reported_name":"Morrone Louis H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2026-02-26T23:52:27.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":63561,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 21,187 on February 24, 2027, 21,187 on February 24, 2028, and 21,187\non February 24, 2029."}],"balance_after":63561,"derivative":{"exercise_price":114.6,"exercise_date":"2027-02-24","expiration_date":"2036-02-23","underlying":"Common Shares","underlying_shares":63561},"source":{"system":"sec-edgar","filing":"0001867666-26-000002","document":"form4-02262026_110221.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000186766626000002/form4-02262026_110221.xml","form_type":"4"}},{"id":312691,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14307,"kind":"person","name":"Morrone Louis H.","position":1,"cik":"0001867666","reported_name":"Morrone Louis H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2026-02-26T23:52:27.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":15418,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":82027,"source":{"system":"sec-edgar","filing":"0001867666-26-000002","document":"form4-02262026_110221.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000186766626000002/form4-02262026_110221.xml","form_type":"4"}},{"id":312699,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2026-02-26T23:43:36.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":57512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 19,170\non February 24, 2027, 19,171 on February 24, 2028, and 19,171 on February 24, 2029."}],"balance_after":57512,"derivative":{"exercise_price":114.6,"exercise_date":"2027-02-24","expiration_date":"2036-02-23","underlying":"Common Shares","underlying_shares":57512},"source":{"system":"sec-edgar","filing":"0001783147-26-000002","document":"form4-02262026_110230.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000178314726000002/form4-02262026_110230.xml","form_type":"4"}},{"id":312698,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14735,"kind":"person","name":"Moreland Mary K","position":1,"cik":"0001783147","reported_name":"Moreland Mary K","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE VICE PRESIDENT"}}],"security":"Common shares without par value","published_at":"2026-02-26T23:43:36.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":13951,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":109534,"source":{"system":"sec-edgar","filing":"0001783147-26-000002","document":"form4-02262026_110230.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000178314726000002/form4-02262026_110230.xml","form_type":"4"}},{"id":312710,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2347,"kind":"person","name":"MCCOY JOHN A. JR.","position":1,"cik":"0001644207","reported_name":"MCCOY JOHN A. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VICE PRESIDENT AND CONTROLLER"}}],"security":"Option (right to buy)","published_at":"2026-02-26T23:35:08.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":22151,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 7,383 on February 24, 2027, 7,384 on February 24, 2028, and 7,384\non February 24, 2029."}],"balance_after":22151,"derivative":{"exercise_price":114.6,"exercise_date":"2027-02-24","expiration_date":"2036-02-23","underlying":"Common Shares","underlying_shares":22151},"source":{"system":"sec-edgar","filing":"0001644207-26-000002","document":"form4-02262026_110204.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000164420726000002/form4-02262026_110204.xml","form_type":"4"}},{"id":312709,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2347,"kind":"person","name":"MCCOY JOHN A. JR.","position":1,"cik":"0001644207","reported_name":"MCCOY JOHN A. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VICE PRESIDENT AND CONTROLLER"}}],"security":"Common shares without par value","published_at":"2026-02-26T23:35:08.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":5373,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":26355,"source":{"system":"sec-edgar","filing":"0001644207-26-000002","document":"form4-02262026_110204.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000164420726000002/form4-02262026_110204.xml","form_type":"4"}},{"id":312714,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14218,"kind":"person","name":"Ford Robert B","position":1,"cik":"0001612571","reported_name":"Ford Robert B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN AND CEO"}}],"security":"Option (right to buy)","published_at":"2026-02-26T23:21:26.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":344066,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 114,688 on February 24, 2027, 114,689 on February 24, 2028, and 114,689 on February 24, 2029."}],"balance_after":344066,"derivative":{"exercise_price":114.6,"exercise_date":"2027-02-24","expiration_date":"2036-02-23","underlying":"Common Shares","underlying_shares":344066},"source":{"system":"sec-edgar","filing":"0001612571-26-000004","document":"form4-02262026_110221.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000161257126000004/form4-02262026_110221.xml","form_type":"4"}},{"id":312713,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14218,"kind":"person","name":"Ford Robert B","position":1,"cik":"0001612571","reported_name":"Ford Robert B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN AND CEO"}}],"security":"Common shares without par value","published_at":"2026-02-26T23:21:26.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":83464,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":336769,"source":{"system":"sec-edgar","filing":"0001612571-26-000004","document":"form4-02262026_110221.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000161257126000004/form4-02262026_110221.xml","form_type":"4"}},{"id":312716,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GROUP PRESIDENT"}}],"security":"Option (right to buy)","published_at":"2026-02-26T23:11:42.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":111533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 37,177 on February 24, 2027, 37,178 on February 24, 2028, and 37,178\n on February 24, 2029."}],"balance_after":111533,"derivative":{"exercise_price":114.6,"exercise_date":"2027-02-24","expiration_date":"2036-02-23","underlying":"Common Shares","underlying_shares":111533},"source":{"system":"sec-edgar","filing":"0001530893-26-000002","document":"form4-02262026_110237.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000153089326000002/form4-02262026_110237.xml","form_type":"4"}},{"id":312715,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14879,"kind":"person","name":"Earnhardt Lisa D","position":1,"cik":"0001530893","reported_name":"Earnhardt Lisa D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GROUP PRESIDENT"}}],"security":"Common shares without par value","published_at":"2026-02-26T23:11:42.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":27056,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":98984,"source":{"system":"sec-edgar","filing":"0001530893-26-000002","document":"form4-02262026_110237.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000153089326000002/form4-02262026_110237.xml","form_type":"4"}},{"id":312661,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14512,"kind":"person","name":"Cushman Elizabeth C.","position":1,"cik":"0002075371","reported_name":"Cushman Elizabeth C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Option (right to buy)","published_at":"2026-02-26T23:01:04.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":61964,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 20,654\non February 24, 2027, 20,655 on February 24, 2028, and 20,655 on February 24, 2029."}],"balance_after":61964,"derivative":{"exercise_price":114.6,"exercise_date":"2027-02-24","expiration_date":"2036-02-23","underlying":"Common Shares","underlying_shares":61964},"source":{"system":"sec-edgar","filing":"0002075371-26-000002","document":"form4-02262026_110256.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000207537126000002/form4-02262026_110256.xml","form_type":"4"}},{"id":312660,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14512,"kind":"person","name":"Cushman Elizabeth C.","position":1,"cik":"0002075371","reported_name":"Cushman Elizabeth C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GC AND SECRETARY"}}],"security":"Common shares without par value","published_at":"2026-02-26T23:01:04.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":15031,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":40257,"source":{"system":"sec-edgar","filing":"0002075371-26-000002","document":"form4-02262026_110256.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000207537126000002/form4-02262026_110256.xml","form_type":"4"}},{"id":312697,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2315,"kind":"person","name":"Boudreau Philip P","position":1,"cik":"0001805099","reported_name":"Boudreau Philip P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND CFO"}}],"security":"Option (right to buy)","published_at":"2026-02-26T22:46:33.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":115413,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 38,471 on February 24, 2027, 38,471 on February 24, 2028, and 38,471 on February 24, 2029."}],"balance_after":115413,"derivative":{"exercise_price":114.6,"exercise_date":"2027-02-24","expiration_date":"2036-02-23","underlying":"Common Shares","underlying_shares":115413},"source":{"system":"sec-edgar","filing":"0001805099-26-000002","document":"form4-02262026_100226.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1800/000180509926000002/form4-02262026_100226.xml","form_type":"4"}},{"id":312696,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2315,"kind":"person","name":"Boudreau Philip P","position":1,"cik":"0001805099","reported_name":"Boudreau Philip P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND CFO"}}],"security":"Common shares without par value","published_at":"2026-02-26T22:46:33.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":27997,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes."}],"balance_after":78613,"source":{"system":"sec-edgar","filing":"0001805099-26-000002","document":"form4-02262026_100226.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000180509926000002/form4-02262026_100226.xml","form_type":"4"}},{"id":314172,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2026-02-06T13:04:16.000Z","date":"2026-02-04","kind":"purchase","planned":false,"acquired":true,"shares":5033,"price":108.3328,"value":545238.9824,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.7700 to $108.7150, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":6738817,"source":{"system":"sec-edgar","filing":"0000902132-26-000003","document":"form4-02062026_010212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1800/000090213226000003/form4-02062026_010212.xml","form_type":"4"}},{"id":314171,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14743,"kind":"person","name":"STARKS DANIEL J","position":1,"cik":"0000902132","reported_name":"STARKS DANIEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares without par value","published_at":"2026-02-06T13:04:16.000Z","date":"2026-02-04","kind":"purchase","planned":false,"acquired":true,"shares":4967,"price":109.1388,"value":542092.4196,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.8150 to $109.5204, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":6733784,"source":{"system":"sec-edgar","filing":"0000902132-26-000003","document":"form4-02062026_010212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000090213226000003/form4-02062026_010212.xml","form_type":"4"}},{"id":314821,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14218,"kind":"person","name":"Ford Robert B","position":1,"cik":"0001612571","reported_name":"Ford Robert B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN AND CEO"}}],"security":"Common shares without par value","published_at":"2026-01-26T13:02:24.000Z","date":"2026-01-23","kind":"purchase","planned":false,"acquired":true,"shares":18800,"price":107.1259,"value":2013966.92,"ownership":{"direct":false,"nature":"Ford Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.735 to $107.485, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Held in the Ford Family Trust DTD June 2, 2014. The reporting person is co-trustee of the trust."}],"balance_after":216203,"source":{"system":"sec-edgar","filing":"0001612571-26-000002","document":"form4-01262026_010121.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000161257126000002/form4-01262026_010121.xml","form_type":"4"}},{"id":315584,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14499,"kind":"person","name":"Stratton John G","position":1,"cik":"0001385262","reported_name":"Stratton John G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2026-01-05T23:46:46.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":313,"price":125.29,"value":39215.77,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":13034,"derivative":{"underlying":"Common Shares","underlying_shares":313},"source":{"system":"sec-edgar","filing":"0001385262-26-000002","document":"form4-01052026_110142.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000138526226000002/form4-01052026_110142.xml","form_type":"4"}},{"id":315558,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14498,"kind":"person","name":"Roman Michael F","position":1,"cik":"0001577544","reported_name":"Roman Michael F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2026-01-05T23:26:09.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":301,"price":125.29,"value":37712.29,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":5882,"derivative":{"underlying":"Common Shares","underlying_shares":301},"source":{"system":"sec-edgar","filing":"0001577544-26-000002","document":"form4-01052026_110105.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000157754426000002/form4-01052026_110105.xml","form_type":"4"}},{"id":315514,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14497,"kind":"person","name":"Gonzalez Patricia Paola","position":1,"cik":"0001879701","reported_name":"Gonzalez Patricia Paola","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2026-01-05T23:15:45.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":263,"price":125.29,"value":32951.27,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":5208,"derivative":{"underlying":"Common Shares","underlying_shares":263},"source":{"system":"sec-edgar","filing":"0001879701-26-000002","document":"form4-01052026_110137.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000187970126000002/form4-01052026_110137.xml","form_type":"4"}},{"id":315559,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2026-01-05T23:00:56.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":62,"price":125.29,"value":7767.98,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":10409,"derivative":{"underlying":"Common Shares","underlying_shares":62},"source":{"system":"sec-edgar","filing":"0001448074-26-000004","document":"form4-01052026_110149.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000144807426000004/form4-01052026_110149.xml","form_type":"4"}},{"id":316226,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14878,"kind":"person","name":"Salvadori Daniel Gesua Sive","position":1,"cik":"0001620564","reported_name":"Salvadori Daniel Gesua Sive","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GROUP PRESIDENT"}}],"security":"Common shares without par value","published_at":"2025-12-12T22:04:36.000Z","date":"2025-12-11","kind":"gift","planned":false,"acquired":false,"shares":1536,"price":123.28,"value":189358.08,"ownership":{"direct":true},"balance_after":132233,"source":{"system":"sec-edgar","filing":"0001620564-25-000009","document":"form4-12122025_101232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000162056425000009/form4-12122025_101232.xml","form_type":"4"}},{"id":316692,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14867,"kind":"person","name":"Shroff Eric","position":1,"cik":"0002058129","reported_name":"Shroff Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common shares without par value","published_at":"2025-11-25T21:17:30.000Z","date":"2025-11-25","kind":"sale","planned":false,"acquired":false,"shares":1586,"price":128.0218,"value":203042.5748,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.02 to $128.06, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":30384,"source":{"system":"sec-edgar","filing":"0002058129-25-000009","document":"form4-11252025_091124.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000205812925000009/form4-11252025_091124.xml","form_type":"4"}},{"id":318354,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14499,"kind":"person","name":"Stratton John G","position":1,"cik":"0001385262","reported_name":"Stratton John G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2025-10-02T21:02:53.000Z","date":"2025-09-30","kind":"grant","planned":false,"acquired":true,"shares":293,"price":133.94,"value":39244.42,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":12663,"derivative":{"underlying":"Common Shares","underlying_shares":293},"source":{"system":"sec-edgar","filing":"0001385262-25-000009","document":"form4-10022025_091040.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000138526225000009/form4-10022025_091040.xml","form_type":"4"}},{"id":318352,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14498,"kind":"person","name":"Roman Michael F","position":1,"cik":"0001577544","reported_name":"Roman Michael F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2025-10-02T20:50:38.000Z","date":"2025-09-30","kind":"grant","planned":false,"acquired":true,"shares":281,"price":133.94,"value":37637.14,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":5556,"derivative":{"underlying":"Common Shares","underlying_shares":281},"source":{"system":"sec-edgar","filing":"0001577544-25-000015","document":"form4-10022025_081034.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000157754425000015/form4-10022025_081034.xml","form_type":"4"}},{"id":318340,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":14497,"kind":"person","name":"Gonzalez Patricia Paola","position":1,"cik":"0001879701","reported_name":"Gonzalez Patricia Paola","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2025-10-02T20:42:16.000Z","date":"2025-09-30","kind":"grant","planned":false,"acquired":true,"shares":246,"price":133.94,"value":32949.24,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board.  The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":4922,"derivative":{"underlying":"Common Shares","underlying_shares":246},"source":{"system":"sec-edgar","filing":"0001879701-25-000007","document":"form4-10022025_081013.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000187970125000007/form4-10022025_081013.xml","form_type":"4"}},{"id":318351,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":10966,"kind":"person","name":"Alpern Robert J","position":1,"cik":"0001448074","reported_name":"Alpern Robert J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Equivalent Units","published_at":"2025-10-02T20:34:54.000Z","date":"2025-09-30","kind":"grant","planned":false,"acquired":true,"shares":58,"price":133.94,"value":7768.52,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."}],"balance_after":10300,"derivative":{"underlying":"Common Shares","underlying_shares":58},"source":{"system":"sec-edgar","filing":"0001448074-25-000011","document":"form4-10022025_081051.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000144807425000011/form4-10022025_081051.xml","form_type":"4"}},{"id":319105,"issuer":{"id":2314,"kind":"organization","name":"ABBOTT LABORATORIES","symbol":"ABT"},"owners":[{"id":2347,"kind":"person","name":"MCCOY JOHN A. JR.","position":1,"cik":"0001644207","reported_name":"MCCOY JOHN A. JR.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VICE PRESIDENT AND CONTROLLER"}}],"security":"Common shares without par value","published_at":"2025-09-03T21:39:50.000Z","date":"2025-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":79,"price":132.66,"value":10480.14,"ownership":{"direct":true},"balance_after":20982,"source":{"system":"sec-edgar","filing":"0001415889-25-023588","document":"form4-09032025_090946.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1800/000141588925023588/form4-09032025_090946.xml","form_type":"4"}}],"next_cursor":"2025-09-03T21:39:50.000000Z,319105"}